Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Extreme restriction is unnecessary and often counterproductive, causing metabolic slowdown that persists beyond the protocol
Compounded medications are tailored to individual patient needs
Memantine is an uncompetitive NMDA receptor antagonist and prevents damage to AD patients caused by NMDA receptor overactivation
Providers often recommend a structured transition plan because both medications affect digestion, appetite, blood sugar levels, and metabolic function
Your LeanMD physician can advise whether switching is appropriate and how to transition safely
US$ 27.20
US$ 22.35
US$ 27.41
US$ 22.02
US$ 23.96
US$ 29.56
US$ 20.10
